In most societies resources are insufficient to provide everyone with all the health care they
want. In practice, this means that some people are given priority over others. On what basis …

Aim: To provide an overview of thresholds for incremental cost–effectiveness ratios (ICERs)
representing willingness-to-pay (WTP) across multiple countries and insights into …

Healthcare decision making is complex. Decision-making processes and the factors
(criteria) that decision makers should consider vary for different types of decisions, including …

Cost–effectiveness analysis is used to compare the costs and outcomes of alternative policy
options. Each resulting cost–effectiveness ratio represents the magnitude of additional …

Abstract The National Institute for Health and Care Excellence (NICE) emphasises that cost‐
effectiveness is not the only consideration in health technology appraisal and is increasingly …

Context National public insurance for drugs is often based on evidence of comparative
effectiveness and cost-effectiveness. This study describes how that evidence has been used …

Purpose To assess the relative cost-effectiveness of genomic testing compared with
standard non-genomic diagnostic investigations in patients with suspected monogenic …

Abstract Objective The Swedish Dental and Pharmaceutical Benefits Agency (TLV) is the
government body responsible for deciding whether outpatient drugs are to be included in …

Abstract Objectives The English National Institute for Health and Care Excellence (NICE)
and the Australian Pharmaceutical Benefits Advisory Committee (PBAC) require evidence …

Abstract The World Health Organization's CHOosing Interventions that are Cost Effective
(WHO-CHOICE) thresholds for averting a disability-adjusted life-year of one to three times …